Multiple sclerosis after allergen-specific immunotherapy and influenza vaccination.
Nakajima
Hideto
H
Division of Neurology, First Department of Internal Medicine, Osaka Medical College, Takatsuki City, Japan. in1045@poh.osaka-med.ac.jp
Ohtsuka
Sizue
S
Nishina
Takuya
T
Sugino
Masakazu
M
Kimura
Fumiharu
F
Hanafusa
Toshiaki
T
Ikemoto
Toshiyuki
T
Shimizu
Akira
A
D000328:Adult; D015496:CD4-Positive T-Lymphocytes / Q000378:metabolism; D003888:Desensitization, Immunologic / Q000009:adverse effects*; D005260:Female; D005434:Flow Cytometry / Q000379:methods; D006801:Humans; D007252:Influenza Vaccines / Q000009:adverse effects* / Q000627:therapeutic use; D009103:Multiple Sclerosis / Q000139:chemically induced*; D054398:Receptors, CCR4; D054367:Receptors, CXCR3; D019707:Receptors, Chemokine / Q000378:metabolism; D012220:Rhinitis / Q000276:immunology / Q000517:prevention & control; D013997:Time Factors; D014611:Vaccination
C515354:CCR4 protein, human; C515187:CXCR3 protein, human; D007252:Influenza Vaccines; D054398:Receptors, CCR4; D054367:Receptors, CXCR3; D019707:Receptors, Chemokine